» Articles » PMID: 24216759

Receptor Tyrosine Kinase Ubiquitylation Involves the Dynamic Regulation of Cbl-Spry2 by Intersectin 1 and the Shp2 Tyrosine Phosphatase

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2013 Nov 13
PMID 24216759
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ubiquitylation of receptor tyrosine kinases (RTKs) regulates their trafficking and lysosomal degradation. The multidomain scaffolding protein intersectin 1 (ITSN1) is an important regulator of this process. ITSN1 stimulates ubiquitylation of the epidermal growth factor receptor (EGFR) through enhancing the activity of the Cbl E3 ubiquitin ligase. However, the precise mechanism through which ITSN1 enhances Cbl activity is unclear. Here, we demonstrate that ITSN1 interacts with and recruits the Shp2 tyrosine phosphatase to Spry2 to enhance its dephosphorylation, thereby disrupting the inhibitory effect of Spry2 on Cbl and enhancing EGFR ubiquitylation. In contrast, expression of a catalytically inactive Shp2 mutant reversed the effect of ITSN1 on Spry2 dephosphorylation and decreased Cbl-mediated EGFR ubiquitylation. In addition, disruption of ITSN1 binding to Spry2 through point mutation of the Pro-rich ITSN1 binding site in Spry2 resulted in decreased Shp2-Spry2 interaction and enhanced Spry2 tyrosine phosphorylation. This study demonstrates that ITSN1 enhances Cbl activity, in part, by modulating the interaction of Cbl with Spry2 through recruitment of Shp2 phosphatase to the Cbl-Spry2 complex. These findings reveal a new level of complexity in the regulation of RTKs by Cbl through ITSN1 binding with Shp2 and Spry2.

Citing Articles

Setting sail: Maneuvering SHP2 activity and its effects in cancer.

Welsh C, Allen S, Madan L Adv Cancer Res. 2023; 160:17-60.

PMID: 37704288 PMC: 10500121. DOI: 10.1016/bs.acr.2023.03.003.


A comprehensive review of SHP2 and its role in cancer.

Asmamaw M, Shi X, Zhang L, Liu H Cell Oncol (Dordr). 2022; 45(5):729-753.

PMID: 36066752 DOI: 10.1007/s13402-022-00698-1.


Cysteine oxidation of copper transporter CTR1 drives VEGFR2 signalling and angiogenesis.

Das A, Ash D, Fouda A, Sudhahar V, Kim Y, Hou Y Nat Cell Biol. 2022; 24(1):35-50.

PMID: 35027734 PMC: 8851982. DOI: 10.1038/s41556-021-00822-7.


Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris.

Chen L, Li J, Yao Y, Wang S, Zheng S, Ju X Bioengineered. 2021; 12(1):1838-1850.

PMID: 33975513 PMC: 8806620. DOI: 10.1080/21655979.2021.1925205.


Redox Regulation of Mitochondrial Fission Protein Drp1 by Protein Disulfide Isomerase Limits Endothelial Senescence.

Kim Y, Youn S, Sudhahar V, Das A, Chandhri R, Cuervo Grajal H Cell Rep. 2018; 23(12):3565-3578.

PMID: 29924999 PMC: 6324937. DOI: 10.1016/j.celrep.2018.05.054.


References
1.
Egan J, Hall A, Yatsula B, Bar-Sagi D . The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc Natl Acad Sci U S A. 2002; 99(9):6041-6. PMC: 122898. DOI: 10.1073/pnas.052090899. View

2.
Pan Y, Carbe C, Powers A, Feng G, Zhang X . Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development. Development. 2010; 137(7):1085-93. PMC: 2835324. DOI: 10.1242/dev.042820. View

3.
Fong C, Leong H, Wong E, Lim J, Yusoff P, Guy G . Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J Biol Chem. 2003; 278(35):33456-64. DOI: 10.1074/jbc.M301317200. View

4.
Hall A, Jura N, DaSilva J, Jang Y, Gong D, Bar-Sagi D . hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr Biol. 2003; 13(4):308-14. DOI: 10.1016/s0960-9822(03)00086-1. View

5.
Oldham C, Mohney R, Miller S, Hanes R, OBryan J . The ubiquitin-interacting motifs target the endocytic adaptor protein epsin for ubiquitination. Curr Biol. 2002; 12(13):1112-6. DOI: 10.1016/s0960-9822(02)00900-4. View